Literature DB >> 2253351

Apolipoprotein E polymorphism determined by restriction enzyme analysis of DNA amplified by polymerase chain reaction: convenient alternative to phenotyping by isoelectric focusing.

K Kontula1, K Aalto-Setälä, T Kuusi, L Hämäläinen, A C Syvänen.   

Abstract

Three common alleles determine six apolipoprotein E (apo E) phenotypes that are associated with variations in serum cholesterol in the population. This genetic variation results from single nucleotide alterations at two DNA loci encoding the amino acid residues 112 and 158 of apo E. We compared results of apo E phenotyping carried out by isoelectric focusing with those of apo E genotyping accomplished by direct DNA analysis. In the latter, the target DNA was amplified by the polymerase chain reaction (PCR) and subsequently analyzed by digestion with the restriction enzyme Hha I, followed by polyacrylamide gel electrophoresis of the cleavage products. With one exception, these two techniques yielded similar results from all 40 samples tested. In addition, a rare variant form of apo E (phenotype E1) was analyzed separately and incorrectly diagnosed as E2 by the Hha I digestion method; the anticipated mutation in the codon 127 was, however, confirmed by demonstration of a new Taq I restriction site in this variant gene. These data confirm that the common isoforms of apo E usually arise from genetic variation of the codons 112 and 158 and demonstrate the feasibility of the PCR technique in apo E genotyping.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253351

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Glycosylation and sialylation of macrophage-derived human apolipoprotein E analyzed by SDS-PAGE and mass spectrometry: evidence for a novel site of glycosylation on Ser290.

Authors:  Youra Lee; Maaike Kockx; Mark J Raftery; Wendy Jessup; Renate Griffith; Leonard Kritharides
Journal:  Mol Cell Proteomics       Date:  2010-05-28       Impact factor: 5.911

2.  Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.

Authors:  C R Harrington; J Louwagie; R Rossau; E Vanmechelen; R H Perry; E K Perry; J H Xuereb; M Roth; C M Wischik
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

3.  Rapid and safe determination of human apolipoprotein E genotypes by miniaturised SDS-PAGE in non-insulin dependent diabetes mellitus.

Authors:  C Clavel; A Durlach; V Durlach; P Birembaut
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

4.  Apolipoprotein ε7 allele in memory complaints: insights through protein structure prediction.

Authors:  Young Chul Youn; Yong Kwan Lim; Su-Hyun Han; Vo Van Giau; Mi-Kyung Lee; Kwang-Yeol Park; SangYun Kim; Eva Bagyinszky; Seong Soo A An; Hye Ryoun Kim
Journal:  Clin Interv Aging       Date:  2017-07-11       Impact factor: 4.458

5.  Pharmacologic concentrations of linezolid modify oxidative phosphorylation function and adipocyte secretome.

Authors:  Laura Llobet; M Pilar Bayona-Bafaluy; David Pacheu-Grau; Elena Torres-Pérez; José M Arbones-Mainar; M Ángeles Navarro; Covadonga Gómez-Díaz; Julio Montoya; Ester López-Gallardo; Eduardo Ruiz-Pesini
Journal:  Redox Biol       Date:  2017-05-31       Impact factor: 11.799

6.  Postoperative cognitive change after cardiac surgery predicts long-term cognitive outcome.

Authors:  Kristiina Relander; Marja Hietanen; Kirsi Rantanen; Juhani Rämö; Antti Vento; Kari-Pekka Saastamoinen; Risto O Roine; Lauri Soinne
Journal:  Brain Behav       Date:  2020-07-17       Impact factor: 2.708

7.  APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer's disease.

Authors:  Qin Zhou; Dantao Peng; Xinrui Yuan; Zeping Lv; Shenghang Pang; Wenyu Jiang; Chuyu Yang; Xiaohong Shi; Guofang Pang; Yige Yang; Haiqun Xie; Wandong Zhang; Caiyou Hu; Ze Yang
Journal:  Neural Regen Res       Date:  2014-03-15       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.